{"@type": "dcat:Dataset", "accessLevel": "public", "accrualPeriodicity": "R/P1Y", "bureauCode": ["009:10"], "contactPoint": {"@type": "vcard:Contact", "fn": "Division of Drug Information", "hasEmail": "mailto:druginfo@fda.hhs.gov"}, "description": "Doxepin Hydrochloride is a generic prescription medication, available as oral capsules in strengths of 10 mg, 25 mg, 50 mg, 75 mg, and 100 mg. Manufactured by Leading Pharma, LLC, it belongs to the tricyclic antidepressant class and is used to treat conditions like depression and anxiety. This information was generated using AI and is provided for informational and research purposes only.", "distribution": [{"@type": "dcat:Distribution", "description": "\n        Access the FDA dataset for Doxepin hydrochloride \u2014 ANDA 207482 submitted by Mylan Institutional LLC\n    ", "downloadURL": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=207482", "mediaType": "text/html", "title": "Doxepin hydrochloride"}], "identifier": "ANDA207482", "issued": "2016-09-16", "keyword": ["drug", "drug-information", "health-care", "medications", "public-health"], "landingPage": "https://www.fda.gov/drugs", "license": "https://open.fda.gov/license", "modified": "2025-03-17", "programCode": ["009:002"], "publisher": {"@type": "org:Organization", "name": "U.S. Food and Drug Administration"}, "theme": ["FDA"], "title": "Doxepin hydrochloride"}